Based on our above finding that IGF1/IGF1R axis facilitated HOXA13 overexpression and CRC metastasis through transactivating ACLY and IGF1R, we hypothesized that whether the combination of ACLY and IGF1R inhibitors had a synergistic effect on CRC treatment. This evidence concerns the gene IGF1 and colorectal carcinoma.